China News Service, May 27. According to foreign media reports, a Belgian woman under the age of 40 developed severe blood clots and thrombocytopenia after receiving the Johnson & Johnson Covid-19 vaccine. She was sent to the hospital on May 21. Died.
The Belgian health department issued a statement on May 26, local time, stating that the country will suspend the use of Johnson & Johnson vaccines in people under 41 years of age.
Data map: European people are vaccinated.
Image source: ICphoto
The statement pointed out that Belgium has requested the European Medicines Agency to investigate the association between the death case and Johnson & Johnson vaccine. The country will wait for the European Medicines Agency to make a more detailed analysis on the safety of the vaccine before deciding whether to cancel. Use age restrictions.
The European Medicines Agency said it has asked Johnson & Johnson to conduct a series of additional studies to help evaluate the possible link between its vaccine and the rare thrombotic disease "thrombosis and thrombocytopenia syndrome."
The European Medicines Agency said on April 20 that the Johnson & Johnson vaccine may be related to the occurrence of blood clots in the vaccinated, but the benefits of vaccination outweigh the risks. EU member states can decide how to use the vaccine.